8-K: Planet 13 Reports Q3 2025 Loss, Exits California

Planet 13 Holdings Inc. announced a significant net loss of $44.0 million for Q3 2025, including a $29.8 million impairment, alongside strategic divestiture of its California operations.

Summary

• Revenue for Q3 2025 was $23.3 million, a decrease of 27.6% compared to $32.2 million in Q3 2024.
• The company reported a net loss of $44.0 million for Q3 2025, significantly wider than the $7.4 million net loss in Q3 2024.
• The net loss includes a $29.8 million non-cash impairment loss.
• Adjusted EBITDA for Q3 2025 was a loss of $4.1 million, compared to a positive Adjusted EBITDA of $1.3 million in Q3 2024.
• Gross profit was $5.0 million or 21.3% in Q3 2025, down from $16.7 million or 51.9% in Q3 2024, primarily due to significant one-time costs related to Florida and California.
• Excluding one-time costs, the underlying gross margin would have been approximately 45%.
• Total expenses increased by 130.8% to $46.2 million, largely due to the $29.8 million impairment loss.
• Operating Expenses decreased by 21.3% to $13.9 million from $17.6 million in Q3 2024.
• Cash stood at $17.2 million as of September 30, 2025, down from $23.4 million at December 31, 2024.
• Total assets decreased to $158.5 million from $206.7 million, while total liabilities increased to $103.9 million from $94.0 million.
• Planet 13 completed the divestiture and closing of its California operations on November 3, 2025.
• The company launched a revamped loyalty program on July 11, 2025, and HaHa branded fast-acting, soft chews in Florida on September 9, 2025.
• New dispensaries were opened in DeLand, Florida (October 13, 2025) and Pace, Florida (October 20, 2025).

Sentiment

Score: 3

Explanation: The Q3 2025 financial results are significantly negative, marked by a substantial net loss, revenue decline, and a large impairment charge. While management expresses optimism about strategic shifts and future improvements, the current financial performance is very weak, indicating significant challenges.

Positives

• Management believes Q3 2025 marked the low point, with sequential improvements observed in October in Nevada and Florida.
• Operating Expenses decreased by 21.3% to $13.9 million in Q3 2025.
• Excluding one-time costs, the underlying gross margin would have been approximately 45%, reflecting the strength of the cultivation platform.
• The divestiture of California operations is expected to eliminate a persistent cash drain and allow focus on more competitive markets.
• The BHO lab is expected to come online by year-end, aiming for improved margins and durable cash flow generation.
• New product launches (HaHa branded fast-acting, soft chews) and a revamped loyalty program aim to enhance customer engagement.
• Expansion in Florida with the opening of two new dispensaries in DeLand and Pace.

Negatives

• Revenue decreased by 27.6% to $23.3 million in Q3 2025, driven by price compression, a weaker consumer environment in Nevada, and increased competition in Florida.
• A significant net loss of $44.0 million was reported, a substantial increase from the $7.4 million net loss in Q3 2024.
• Adjusted EBITDA shifted to a loss of $4.1 million from a positive $1.3 million in the prior year period.
• Gross profit margin significantly declined to 21.3% from 51.9%, impacted by substantial one-time costs.
• Total expenses surged by 130.8% due to a $29.8 million non-cash impairment loss.
• Cash reserves decreased to $17.2 million from $23.4 million at the end of the previous fiscal year.
• Total assets declined by $48.2 million, while total liabilities increased by $9.9 million.

Risks

• Uncertainty regarding final regulatory and other approvals or consents needed to operate the business.
• Fluctuations in general macroeconomic conditions and inflationary pressures.
• Fluctuations in securities markets.
• Challenges in achieving expectations regarding the size of the cannabis market and adapting to changing consumer habits.
• The Company's ability to successfully achieve its business objectives and plans for expansion.
• Political and social uncertainties, including international conflict.
• Potential inability to obtain adequate insurance to cover risks and hazards.
• The presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products.
• Employee relations issues.

Future Outlook

Management anticipates Q3 2025 to be the lowest point, with sequential improvements already observed in October for both Nevada and Florida. The company is focused on disciplined operations, improved margins, and durable cash flow generation, with the BHO lab expected to be operational by year-end. Resources will be concentrated on Nevada and Florida, markets where the company believes it holds clear competitive advantages and strong return potential.

Management Comments

• "Q3 marked the low point for Planet 13. We took decisive action to address our cost structure and operational challenges, reducing SG&A significantly and taking impairment and inventory reserve charges to clean up our balance sheet. Excluding these one-time items, our underlying gross margin would have been approximately 45% reflecting the strength of our cultivation platform and our ability to compete on price while maintaining healthy economics. October's sequential improvements in both Nevada and Florida validate that we've turned the corner." Larry Scheffler, Co-CEO
• "We've made the difficult but necessary decisions to position Planet 13 for sustainable operations. Exiting California eliminates a persistent cash drain and allows us to focus our resources on Nevada and Florida, markets where we have clear competitive advantages and paths to strong returns. With our BHO lab coming online by year-end and early momentum building in Q4, we're executing against a clear roadmap: disciplined operations, improved margins, and durable cash flow generation." Bob Groesbeck, Co-CEO

Industry Context

The cannabis industry is experiencing challenges, as indicated by Planet 13's decreased sales driven by price compression and a weaker consumer environment in Nevada, alongside increased competition in Florida. This suggests a broader trend of market saturation and pricing pressures impacting revenue and profitability for multi-state operators. The strategic decision to exit California reflects a move by some companies to consolidate operations and focus on markets with clearer paths to profitability amidst a challenging regulatory and competitive landscape.

Stakeholder Impact

• Shareholders: Will experience a significant negative impact on equity due to the large net loss and impairment, potentially affecting share price. The strategic shift may offer long-term value but introduces near-term uncertainty.
• Employees: Those in California operations are directly impacted by the divestiture. Employees in Nevada and Florida may see increased focus and resource allocation.
• Customers: New loyalty programs and product launches aim to enhance customer experience and retention. New dispensaries in Florida expand access for customers in those regions.
• Creditors: Increased total liabilities and reduced cash may lead to closer scrutiny, though management's focus on cash flow generation aims to mitigate concerns.

Next Steps

• Focus resources and operational efforts on the Nevada and Florida markets.
• Bring the BHO lab online by year-end to improve margins and cash flow.
• Execute against a clear roadmap emphasizing disciplined operations, improved margins, and durable cash flow generation.
• Host a conference call on November 12, 2025, to discuss Q3 financial results, business highlights, strategy, and outlook.

Key Dates

Recommendation

The Q3 2025 results are exceptionally poor, featuring a substantial net loss, a significant revenue decline, and a negative Adjusted EBITDA, exacerbated by a large impairment charge. While the strategic exit from California is a necessary step to stem losses, the overall financial deterioration suggests deep operational challenges. The company's path to sustainable profitability remains highly uncertain in a competitive and price-pressured market. Given the severe underperformance and increased liabilities, a seasoned investor would likely recommend selling to mitigate further downside risk.

Keywords

Cannabis, Marijuana, Dispensary, Vertically Integrated, Multi-state Operator, MSO, Nevada, Florida, Q3 2025, Financial Results, Earnings, Planet 13, PLTH, PLNH, SEC Filing, 8-K, Impairment, Divestiture, California Exit, Adjusted EBITDA